title: Sildenafil in bronchopulmonary dysplasia: safe to use?
authors.affiliation: Department of Paediatrics, Imperial College, London, UK.
authors.forename: Andrew James
authors.initials: AJ
authors.lastname: Wardle
authors.affiliation: Department of Paediatrics, Bristol Royal Hospital for Children, Bristol, UK.
authors.forename: Georgia May
authors.initials: GM
authors.lastname: Connolly
authors.affiliation: North West Thames Foundation School, London, UK.
authors.forename: Tom
authors.initials: T
authors.lastname: Stonier
authors.affiliation: Department of Cardiology, Bristol Royal Hospital for Children, Bristol, UK.
authors.forename: Robert
authors.initials: R
authors.lastname: Tulloh
mesh_terms: D001997:Bronchopulmonary Dysplasia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D004452:Echocardiography; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D007231:Infant, Newborn; D058986:Phosphodiesterase 5 Inhibitors / Q000008:administration & dosage; D010879:Piperazines / Q000008:administration & dosage*; D011669:Pulmonary Wedge Pressure; D011687:Purines / Q000008:administration & dosage; D000068677:Sildenafil Citrate; D013449:Sulfonamides / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D010879:Piperazines; D011687:Purines; D013449:Sulfonamides; D000068677:Sildenafil Citrate
keywords: Bronchopulmonary dysplasia; Pulmonary hypertension; Sildenafil